The online version of this article (https://doi.org/10.1186/s13613-017-0349-3) contains supplementary material, which is available to authorized users.
Statins can exert pleiotropic anti-inflammatory, vascular protective and anticoagulant effects, which in theory could improve the dysregulated host response during sepsis. We aimed to determine the association between prior statin use and host response characteristics in critically ill patients with sepsis.
We performed a prospective observational study in 1060 patients admitted with sepsis to the mixed intensive care units (ICUs) of two hospitals in the Netherlands between January 2011 and July 2013. Of these, 351 patients (33%) were on statin therapy before admission. The host response was evaluated by measuring 23 biomarkers providing insight into key pathways implicated in sepsis pathogenesis and by analyzing whole-blood leukocyte transcriptomes in samples obtained within 24 h after ICU admission. To account for indication bias, a propensity score-matched cohort was created (N = 194 in both groups for protein biomarkers and N = 95 in both groups for gene expression analysis).
Prior statin use was not associated with an altered mortality up to 90 days after admission (38.0 vs. 39.7% in the non-statin users in the propensity-matched analysis). Statin use did not modify systemic inflammatory responses, activation of the vascular endothelium or the coagulation system. The blood leukocyte genomic response, characterized by over-expression of genes involved in inflammatory and innate immune signaling pathways as well as under-expression of genes associated to T cell function, was not different between patients with and without prior statin use.
Statin therapy is not associated with a modified host response in sepsis patients on admission to the ICU.
Additional file 1: Figure 1. Flowchart of patients. Figure 2. Distribution of propensity scores. Figure 3. Blood transcriptomics of sepsis patients discordant for statin therapy. Table 1. Host response biomarkers in sepsis patients admitted to the ICU stratified according to prior use of statins in the unmatched cohort. Table 2. Baseline characteristics of matched statin-users and non-users in the gene expression study. Table 3. Outcomes of matched statin-users and non-users in the gene expression study.
Bedi O, Dhawan V, Sharma PL, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn-Schmiedeberg’s Arch Pharmacol. 2016;389:695–712. CrossRef
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12. CrossRefPubMedPubMedCentral
Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–33.
Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by “surrogate variable analysis”. PLoS Genet. 2005;preprint:e161.
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015. http://www.R-project.org.
National Heart L, Blood Institute ACTN, Truwit JD, Bernard GR, Steingrub J, Matthay MA, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191–200. CrossRef
Papazian L, Roch A, Charles P-E, Penot-Ragon C, Perrin G, Roulier P, et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA J Am Med Assoc. 2013;310:1692–700. CrossRef
Wiewel MA, de Stoppelaar SF, van Vught LA, Frencken JF, Hoogendijk AJ, Klein Klouwenberg PM, et al. Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis. Intensive Care Med. 2016;42:352–60. CrossRefPubMedPubMedCentral
- The host response in critically ill sepsis patients on statin therapy: a prospective observational study
Maryse A. Wiewel
Brendon P. Scicluna
Lonneke A. van Vught
Arie J. Hoogendijk
Aeilko H. Zwinderman
Olaf L. Cremer
Marc J. Bonten
Marcus J. Schultz
Tom van der Poll
- Springer International Publishing
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
e.Med Kampagnen-Visual, Mail Icon II